Abstract
ObjectiveThis trial compared the efficacy and safety of transarterial chemoembolisation (TACE) plus sorafenib with TACE alone using a newly established TACE-specific endpoint and pre-treatment of sorafenib before initial TACE.DesignPatients with...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have